Achievement of immunocompetent and therapeutic T lymphopoiesis from pluripotent stem cells (PSCs) is a central aim in T cell regenerative medicine. To date, preferentially reconstituting T lymphopoiesis in vivo from PSCs remains a practical challenge. Here we documented that synergistic and transient expression of Runx1 and Hoxa9 restricted in the time window of endothelial-tohematopoietic transition and hematopoietic maturation stages in a PSC differentiation scheme (iR9-PSC) in vitro induced preferential generation of engraftable hematopoietic progenitors capable of homing to thymus and developing into mature T cells in primary and secondary immunodeficient recipients. Single-cell transcriptome and functional analyses illustrated the cellular trajectory of T lineage induction from PSCs, unveiling the T-lineage specification determined at as early as hemogenic endothelial cell stage and identifying the bona fide pre-thymic progenitors. The induced T cells distributed normally in central and peripheral lymphoid organs and exhibited abundant TCRαβ repertoire. The regenerative T lymphopoiesis restored immune surveillance in immunodeficient mice. Furthermore, gene-edited iR9-PSCs produced tumor-specific T cells in vivo that effectively eradicated tumor cells. This study provides insight into universal generation of functional and therapeutic T cells from the unlimited and editable PSC source.
Deletion of B cell master regulators reprogrammed B cells into T cells that were either functional defects or tumorigenic potential. Here we show that Hoxb5, which is expressed in uncommitted hematopoietic progenitors but absent in committed B and T lineages, could reprogram pro-pre-B cells into functional early T cell progenitors. The reprogramming started in bone marrow and completed in thymus, giving rise to T lymphocytes with transcriptomes, hierarchical differentiation, tissue distribution and immune functions closely resembling their natural counterparts. Hoxb5 repressed B cell master genes, activated T cell regulators and regulated crucial chromatin modifiers in pro-pre-B cells, ultimately driving B to T cell fate conversion. Our results provide a de novo paradigm for generating normal and functional T cells through reprogramming in vivo.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.